Tetragon Partners Gp Ltd

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$515.1M
Q ending 2026-03-31
Prior quarter
$474.3M
Q ending 2025-12-31
Change
+8.6% QoQ · +17.6% YoY
Positions
36
reported holdings

Largest positions

All 36 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Uipath IncPATHShares$279.8M25.2M
Kolibri Global Energy IncKGEIShares$37.5M6.8M
Warner Bros Discovery IncWBDShares$25.4M924K
Workiva IncWKShares$14.9M250K
Lyft IncLYFTShares$13.3M1.0M
Sprinklr IncCXMShares$13.2M2.2M
Autolus Therapeutics LtdAUTLShares$13.1M9.5M
Celldex Therapeutics Inc NewCLDXShares$9.9M312K
Arrowhead Pharmaceuticals InARWRShares$8.0M127K
Nektar TherapeuticsNKTRShares$7.4M103K
Annexon IncANNXShares$7.2M1.3M
Pharvaris N VShares$6.3M222K
Axsome Therapeutics Inc.AXSMCall$5.9M35K
Alkermes PlcShares$5.7M160K
Agios Pharmaceuticals IncAGIOShares$5.6M165K
Immunovant IncIMVTShares$5.4M219K
Praxis Precision Medicines IPRAXShares$5.1M16K
Krystal Biotech IncKRYSShares$5.1M20K
Dyne Therapeutics IncDYNShares$4.7M258K
Amylyx Pharmaceuticals IncAMLXShares$4.4M318K
Mbx Biosciences IncMBXShares$4.3M145K
Definium Therapeutics IncDFTXShares$3.8M200K
Soleno Therapeutics IncSLNOEURShares$3.4M102K
Axsome Therapeutics Inc.AXSMShares$3.4M20K
Harmony Biosciences Hldgs InHRMYShares$3.3M119K
Silence Therapeutics PlcSLNShares$3.3M630K
Acadia Pharmaceuticals IncACADShares$3.2M145K
Ionis Pharmaceuticals IncIONSShares$3.1M42K
Maplight Therapeutics IncMPLTShares$2.3M112K
Relay Therapeutics IncRLAYShares$1.8M182K
Snowflake IncSNOWShares$1.5M10K
Aardvark Therapeutics IncAARDShares$1.2M317K
Tectonic Therapeutic IncTECXShares$1.2M38K
Ultragenyx Pharmaceutical InRAREShares$827K39K
Karyopharm Therapeutics IncKPTIShares$295K53K
Karyopharm Therapeutics IncKPTICall$279K50K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.